StageAsset Sale | AssetsPurchased
CoAxia is a development stage, private, venture-backed medical device company in clinical trials with an innovative, catheter-based therapy for the treatment of cerebral ischemia, most notably: ischemic stroke. CoAxia's business focus is demonstrating the safety and efficacy of its NeuroFlo catheter and making it a standard treatment option hundreds of thousands of stroke patients worldwide. In addition, CoAxia is in limited distribution of NeuroFlo to treat cerebral vasospasm, under an HDE market approval from the FDA. CoAxia holds several key patents on the concept and implementation of cerebral perfusion augmentation as well as numerous other patents relevant to various vascular disorders.
Missing: CoAxia's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: CoAxia's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
CoAxia has filed 7 patents.
Arteries of the head and neck, Vascular diseases, Neurological disorders, Interventional radiology, Stroke
Arteries of the head and neck, Vascular diseases, Neurological disorders, Interventional radiology, Stroke
Latest CoAxia News
Jul 2, 2013
Atlas Vac Machine offers All Electric medical device tray sealer Atlas Vac Machine’s lineup of tray sealers includes an All Electric Sealer design with no pneumatics. In seeking the ultimate in precise down-force control, our engineers have replaced the traditional pneumatic press with the next generation of press drive systems. Coupled with the heaviest heater & platen cross section in the industry, electric auto shuttles and […] UV Disinfection continues to grow in infection control Ultraviolet Light Disinfection is not a new technology to many industries, but more and more experts are utilizing the technology in the growing concern of providing infection control in hospitals globally. The most recent area of the world to take an interest in using UV in these capacities is Canada. UV disinfection works by utilizing […] SL Power’s new MU425S AC/DC power supply family improves medical equipment power performance SL Power Electronics, a division of SL Industries and an industry leader in the design and manufacture of rugged, highly reliable power supplies, today announces its 425 watt, single output MU425 Series AC/DC power supply. This latest offering addresses the complexity and unique power needs of healthcare systems such as surgical equipment, home healthcare therapeutic […] Newport introduces 2-inch, vertical drive mirror mount for industrial application Newport Corporation, a worldwide leader in photonic solutions, expands its industry leading portfolio of opto-mechanics with the HVM-2i, a compact and robust vertical drive kinematic mount for 2 inch diameter optics. The HVM-2i features a unique ball-and-wedge drive mechanism that enhances the overall performance of the optical mount by reducing stiction and backlash to negligible […] Multiple factors determine the best alternative to DEHP for PVC medical devices by Peter M. Galland, Industry Manager for Regulated Compounds, Teknor Apex Company While phthalate esters such as DEHP are the most widely used plasticizers for flexible PVC medical compounds and have been for fifty years, issues concerning their possible effects on human health have caused some device manufacturers to consider compounds containing alternative plasticizers. Sometimes […] Bone Biologics completes $5.75 Million round of financing Bone Biologics, an orthobiologic company focused on regenerative medicine, announced today the completion of a $5.75 million funding round with Musculoskeletal Transplant Foundation, OrthoFix Holdings, Inc. and Hankey Capital, LLC. Proceeds will be used primarily to fund further development and synthesis of a potential bone graft substitute product focused first on bone regeneration in spinal […] MR Solutions wins Queen’s Award for Enterprise MR Solutions, of Guildford has won the prestigious Queen’s Award for Enterprise in the innovation category. This award is announced on the Queen’s birthday, 21 April and is one of the UK’s highest accolades recognizing business achievement. This has been achieved in recognition of MR Solutions’ development of a preclinical multi-modality MRI scanner which does […] UL experts aim to “raise the baseline” in cybersecurity Industry is facing increasing risk of both unintentional and malignant cyber threats, and an increasing sense of responsibility to protect against those factors. Cyber threats continue to be a high priority for medical technology companies, but there are continued questions on how and where to introduce security measures. Now, UL says the process should be […] Materialise NV, Canon ink Japanese distro deal Materialise NV said today it inked a distribution deal with Canon Lifecare Solutions to distribute its Materialise Mimics Innovation software and care suits in Japan. Through the agreement, workstations and 3D printers offered by Canon Lifecare Solutions will be offered with Materialise’s open software solutions, including the newly launched Materialise Mimics inPrint designed to allow […] Lubrizol LifeSciences adds commercial manufacturing capacity at Particle Sciences The Lubrizol Corporation’s LifeSciences, the leading contract development and manufacturing organization (CDMO) for complex drug products, is adding commercial drug product manufacturing capacity at its Particle Sciences facility in Bethlehem, PA. The 18,000 square foot capacity will include both sterile and non-sterile space with complete lyophilization and filling operations. Among other things, the facility will […] LED illumination system, ilumCURE, for the industrial applications In automated manufacturing processes up to 127 ilumCURE devices are controlled individually from a single PC to perform punctual or wide area exposures with adjustable intensity and duration. The operating states of the devices can be monitored remotely to detect issues within automated production. Reproducible hardening processes are ensured by a controller-operated LED current measurement […] Leave a Reply You must be logged in to post a comment. Need Medtech news in a minute? We Deliver! MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today. Tweets by @MassDevice Need Medtech news in a minute? We Deliver! MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today. Medical Design & Outsourcing covers the technical advancements in design, development, and contract manufacturing of medical devices and equipment. DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights. Follow us
CoAxia Frequently Asked Questions (FAQ)
When was CoAxia founded?
CoAxia was founded in 1999.
Where is CoAxia's headquarters?
CoAxia's headquarters is located at 10900 73rd Avenue North, Maple Grove.
What is CoAxia's latest funding round?
CoAxia's latest funding round is Asset Sale.
How much did CoAxia raise?
CoAxia raised a total of $80.35M.
Who are the investors of CoAxia?
Investors of CoAxia include ZOLL Medical, Affinity Capital Management, Johnson & Johnson Innovation, Canaan Partners, Prism VentureWorks and 6 more.
Who are CoAxia's competitors?
Competitors of CoAxia include MicroTransponder, Mercator MedSystems, Concentric Medical, VasoNova, Micrus Endovascular and 9 more.
Compare CoAxia to Competitors
DuoCure offers intraluminal minimally invasive implantable device for treatment of obesity.
Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). An aneurysm is a weakening of the wall of the aorta, the largest artery of the body. Aortic aneurysm disease is a cause of death in the United States and it is estimated that 1.7 million persons over 55 years of age have an AAA. Each year, physicians diagnose approximately 200,000 people in the United States with AAA. Endologix is currently marketing its Powerlink Delivery System a, one-piece endoluminal stent graft (ELG) used in treating AAA that has significant advantages when compared with marketed stent alternatives. Powerlink has been commercially available in Europe since 1999. FDA approval for the Powerlink AAA stent graft was received on October 29, 2004. The Powerlink superior design is covered by 17 U.S. patents with 361 allowed claims; the technology is designed to overcome shortcomings of first-generation ELGs. The device is for sale in the United States and selected international markets. Endologix is a publicly-held company trading on NASDAQ: ELGX. The company's corporate office is located in Irvine, California.
ProRhythm has developed a HIFU balloon catheter that can shorten and simplify ablation procedures. The product is designed to create circumferential lesions within the left atrium of the heart to treat Atrial Fibrillation.
Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.
Mercator MedSystems has developed a broad-based therapeutic platform that allows clinicians to accurately and efficiently deliver drugs and biologics such as stem cells to tissues deep in the body, treating the root cause of significant medical conditions. The company utilizes its family of Micro-Infusion Catheters for targeted treatments via the vascular system, including peripheral artery disease (PAD) and resistant hypertension (HTN); and via the bronchial tree, including malignant airway obstruction secondary to lung cancer. The company's 510(k)-cleared and CE-Marked Cricket and Bullfrog Micro-Infusion Catheters are vascular-access systems that are able to inject drugs, genes, and cells safely through vessel walls into deep tissues without major surgery.
Rafael Medical has developed a novel anchoring system for safely implanting and retrieving a wide range of intra-vascular devices in a minimally invasive manner. Based on the technology, diagnostic and therapeutic devices can be delivered into small and large blood vessels alike by way of a small-sized delivery system. Following the completion of the SafeFlo Filter the company is now developing additional devices geared to the interventional cardiology market.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.